Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579462 · ClinicalTrials.gov registry record
Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 281
- Enrollment target
NCT00579462: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00579462 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 281 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579462 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 281 participants
- Enrollment target
Study Summary
The purpose of this study is to study whether the presence of lung cancer in your body can be detected by testing the blood, and if the results of these blood tests change as your tumor shrinks or grows.
Interventions
- OTHER Blood and Tissue studies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 281 participants |
| Start Date | 2003-01 |
| Est. Completion | 2010-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579462
The ClinicalTrials.gov registry entry for NCT00579462 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 281 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood and Tissue studies is the first listed.
NCT00579462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00579462 about?
NCT00579462 is a clinical study titled "Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer". The purpose of this study is to study whether the presence of lung cancer in your body can be detected by testing the blood, and if the results of these blood tests change as your tumor shrinks or grows.
What is the current status of trial NCT00579462?
This trial is currently completed. The enrollment target is 281 participants. The study started on 2003-01. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00579462?
The interventions under investigation include: Blood and Tissue studies (OTHER).
Who is sponsoring clinical trial NCT00579462?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.